Simplify Health Care ETF Rating $29.66 -0.11 (-0.37%) As of 06/13/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Simplify Health Care ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PINK Aggregate RatingModerate Buy 2.83Holdings in PINK have an aggregate rating of Moderate Buy based on 909 analyst ratings issued in the past year covering 61 companies (100.0% of the portfolio).PINK Aggregate Price Target$29.66High Prediction$29.66Average Prediction$29.66Low Prediction$29.66Holdings in PINK have an aggregate price target of $29.66 and a range of $29.66 to $29.66 covering 61 companies (100.0% of the portfolio).PINK Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy40 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 61 PINK Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.15%LLYEli Lilly and Company$818.56+0.8%4.8391 of 5 stars2.76$1,011.37 23.6%21Trending NewsAnalyst Revision6.77%ARQTArcutis Biotherapeutics$13.43-0.5%1.8792 of 5 stars2.83$18.80 40.0%6Positive NewsGap Up5.69%DHRDanaher$200.51-2.2%4.8163 of 5 stars2.80$248.17 23.8%20Positive News5.14%ADMAADMA Biologics$20.81-3.7%2.3471 of 5 stars3.25$24.25 16.5%4Positive NewsInsider TradeAnalyst Revision5.09%PMPhilip Morris International$184.010.0%4.1258 of 5 stars2.91$176.80 -3.9%11Trending NewsDividend AnnouncementAnalyst Forecast4.81%ISRGIntuitive Surgical$512.18-0.2%4.7548 of 5 stars2.70$588.95 15.0%204.13%PCTPureCycle Technologies$11.34-2.8%1.1214 of 5 stars2.75$12.00 5.8%4Positive NewsAnalyst UpgradeAnalyst RevisionGap Down4.04%SNYSanofi$49.67-2.3%3.3642 of 5 stars3.13$61.50 23.8%8Short Interest ↑Analyst RevisionGap Down3.73%ABBVAbbVie$190.67-0.9%4.9038 of 5 stars2.81$211.29 10.8%27Trending NewsAnalyst ForecastAnalyst Revision3.68%REGNRegeneron Pharmaceuticals$529.24+1.4%4.8812 of 5 stars2.85$836.48 58.1%26Positive NewsAnalyst Revision2.98%INSMInsmed$98.73+1.9%3.2944 of 5 stars3.00$104.81 6.2%18Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume2.89%CAHCardinal Health$161.28+0.5%4.4313 of 5 stars2.79$157.43 -2.4%14Trending NewsAnalyst ForecastAnalyst Revision2.64%DGXQuest Diagnostics$180.04+0.6%4.856 of 5 stars2.69$185.73 3.2%16Positive News2.53%PCRXPacira BioSciences$24.24-0.9%2.4659 of 5 stars2.33$26.44 9.1%9Positive News2.43%DXCMDexCom$81.99-1.0%4.7902 of 5 stars2.95$98.32 19.9%212.31%WGSGeneDx$64.57-2.7%3.6847 of 5 stars2.75$86.75 34.4%8News CoverageGap Down2.30%PODDInsulet$304.63+0.3%4.2885 of 5 stars2.82$318.41 4.5%17Analyst Downgrade2.23%BSXBoston Scientific$99.60+1.1%4.5738 of 5 stars3.09$116.00 16.5%22Positive News2.08%CORCencora$295.12+0.0%4.5524 of 5 stars2.90$306.91 4.0%10Positive News1.98%RMDResMed$249.16-1.2%4.0413 of 5 stars2.60$259.33 4.1%15Positive NewsInsider Trade1.86%AZNAstraZeneca$74.42-0.8%2.8704 of 5 stars3.13$85.00 14.2%8Positive NewsAnalyst Revision1.66%GILDGilead Sciences$109.98-1.8%4.9101 of 5 stars2.78$110.55 0.5%27Trending NewsOptions VolumeAnalyst Revision1.42%ALHCAlignment Healthcare$14.94-0.9%1.4601 of 5 stars2.64$17.17 14.9%11News CoverageInsider Trade1.39%GEHCGE HealthCare Technologies$72.25-1.2%4.1108 of 5 stars2.83$88.27 22.2%121.23%BHVNBiohaven$15.43-1.1%2.987 of 5 stars3.07$59.46 285.5%15Short Interest ↑Analyst Revision1.23%JNJJohnson & Johnson$156.90+0.2%4.765 of 5 stars2.55$170.88 8.9%20Trending News1.13%TFXTeleflex$119.93-1.8%4.7789 of 5 stars2.09$164.63 37.3%111.05%ABTAbbott Laboratories$135.41-0.8%4.9319 of 5 stars2.84$142.59 5.3%19Trending NewsDividend Announcement1.05%RVTYRevvity$93.47-2.3%3.8532 of 5 stars2.80$125.64 34.4%15Positive News0.96%UNHUnitedHealth Group$313.39-1.6%4.9993 of 5 stars2.60$426.52 36.1%25Trending NewsAnalyst DowngradeInsider TradeAnalyst Revision0.82%GHGuardant Health$49.29+0.6%3.7384 of 5 stars3.00$53.76 9.1%21Analyst Forecast0.74%BNTCBenitec Biopharma$16.48+3.5%2.4866 of 5 stars3.22$23.83 44.6%9Positive News0.70%ARGXargenx$577.89-1.5%3.4814 of 5 stars3.05$709.18 22.7%22Analyst Forecast0.69%TMOThermo Fisher Scientific$402.12-3.2%4.9696 of 5 stars2.80$605.30 50.5%20Trending News0.65%CASHPathward Financial$74.37-2.1%3.5998 of 5 stars2.50$92.00 23.7%2Positive NewsDividend Announcement0.60%NBIXNeurocrine Biosciences$124.39-0.5%4.9109 of 5 stars2.86$162.00 30.2%22Positive NewsAnalyst Revision0.54%EWEdwards Lifesciences$75.12-1.0%4.5602 of 5 stars2.40$80.20 6.8%25Positive News0.49%LGNDLigand Pharmaceuticals$112.50-1.7%4.3938 of 5 stars3.00$146.14 29.9%7News CoveragePositive News0.44%RAREUltragenyx Pharmaceutical$37.49-4.6%4.4118 of 5 stars2.92$88.77 136.8%13Analyst Revision0.40%COOCooper Companies$69.70-1.7%3.2602 of 5 stars2.60$100.38 44.0%100.39%CVSCVS Health$67.42+1.6%4.9862 of 5 stars2.95$75.07 11.3%19Trending NewsAnalyst Revision0.39%CIThe Cigna Group$317.03+0.5%4.9761 of 5 stars2.95$380.39 20.0%19Trending NewsAnalyst Revision0.38%VRTXVertex Pharmaceuticals$455.45-1.0%4.6356 of 5 stars2.57$515.04 13.1%30Positive NewsAnalyst Revision0.38%FULCFulcrum Therapeutics$6.85+1.0%0.4244 of 5 stars2.50$6.29 -8.2%8Positive NewsAnalyst RevisionGap Down0.37%EYPTEyePoint Pharmaceuticals$9.03+1.9%2.1963 of 5 stars3.00$25.38 181.0%9Analyst RevisionGap Down0.34%SYKStryker$377.01-0.9%4.9116 of 5 stars2.79$427.30 13.3%19Positive NewsAnalyst Upgrade0.29%LIVNLivaNova$45.76-1.9%3.4594 of 5 stars3.00$59.29 29.6%80.28%TGTXTG Therapeutics$36.01-3.6%3.5103 of 5 stars2.80$40.80 13.3%5Positive NewsAnalyst RevisionGap Down0.25%LPTXLeap Therapeutics$0.41-2.9%2.6895 of 5 stars2.25$4.92 1,099.5%4Positive NewsGap Down0.23%CHWYChewy$41.62+1.0%3.0284 of 5 stars2.68$43.72 5.0%25Trending NewsEarnings ReportAnalyst Forecast0.20%SNDXSyndax Pharmaceuticals$10.25-3.9%2.9323 of 5 stars2.91$35.91 250.3%11News Coverage0.19%MMM3M$142.17-1.8%4.4777 of 5 stars2.54$155.83 9.6%13Positive NewsAnalyst Forecast0.18%AGLagilon health$2.16-1.6%3.0161 of 5 stars2.17$4.79 122.1%18Gap Down0.15%ZBHZimmer Biomet$91.23-2.2%4.9002 of 5 stars2.29$111.53 22.2%21Positive News0.11%SRPTSarepta Therapeutics$36.18-3.0%4.7072 of 5 stars2.87$122.61 238.9%230.08%ICLRICON Public$145.66-1.0%4.6998 of 5 stars2.60$213.08 46.3%150.06%ESTAEstablishment Labs$37.44+0.9%2.6833 of 5 stars2.80$52.40 40.0%5News CoverageAnalyst Forecast0.03%VLTOVeralto$97.20-1.6%4.1826 of 5 stars2.45$110.09 13.3%11Positive News0.02%BMYBristol-Myers Squibb$49.71-1.9%4.8086 of 5 stars2.32$58.00 16.7%22Positive NewsAnalyst Revision0.01%PRAXPraxis Precision Medicines$44.30-1.6%2.7652 of 5 stars2.80$109.90 148.1%10Positive NewsAnalyst Forecast0.01%EMBCEmbecta$9.56-4.8%4.25 of 5 stars2.33$19.33 102.2%3 This page (NYSEARCA:PINK) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PINK Stock Free PINK Stock Alerts